Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome

Similar Items

• Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome - authors' response
  od: Toms, Tracey E, i dr.
  Izdano: (2009)
• Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
  od: van Halm, Vokko P, i dr.
  Izdano: (2006)
• Are biologics more effective than classical disease-modifying antirheumatic drugs?
  od: Nurmohamed, Michael T, i dr.
  Izdano: (2008)
• The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
  od: Raterman, Hennie G, i dr.
  Izdano: (2012)
• Cyclosporin and methotrexate therapy
  od: Conaghan, P, i dr.
  Izdano: (2003)